PCNA EXPRESSION IN LUNG-CANCER CELLS EXPRESSING MUTANT P53 PROTEINS

被引：0
|
作者：
MINIMO, C [1 ]
LIN, D [1 ]
CORREA, I [1 ]
FITZPATRICK, B [1 ]
MERCER, WE [1 ]
BIBBO, M [1 ]
机构：
[1] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,PHILADELPHIA,PA 19107
来源：
LABORATORY INVESTIGATION | 1994年 / 70卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A142 / A142
页数：1
相关论文
共 50 条
  • [21] SERUM P53 ANTIBODIES AS EARLY MARKERS OF LUNG-CANCER
    LUBIN, R
    ZALCMAN, G
    BOUCHET, L
    TREDANIEL, J
    LEGROS, Y
    CAZALS, D
    HIRSCH, A
    SOUSSI, T
    NATURE MEDICINE, 1995, 1 (07) : 701 - 702
  • [22] ALLELIC FREQUENCY OF A P53 POLYMORPHISM IN HUMAN LUNG-CANCER
    WESTON, A
    PERRIN, LS
    FORRESTER, K
    HOOVER, RN
    TRUMP, BF
    HARRIS, CC
    CAPORASO, NE
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1992, 1 (06) : 481 - 483
  • [23] P53 - A FREQUENT TARGET FOR GENETIC ABNORMALITIES IN LUNG-CANCER
    TAKAHASHI, T
    NAU, MM
    CHIBA, I
    BIRRER, MJ
    ROSENBERG, RK
    VINOCOUR, M
    LEVITT, M
    PASS, H
    GAZDAR, AF
    MINNA, JD
    SCIENCE, 1989, 246 (4929) : 491 - 494
  • [24] Human lung cancer cells endogenously expressing mutant p53 process and present the mutant epitope and are lysed by mutant-specific cytotoxic T lymphocytes
    Ciernik, IF
    Berzofsky, JA
    Carbone, DP
    CLINICAL CANCER RESEARCH, 1996, 2 (05) : 877 - 882
  • [25] WILD-TYPE BUT NOT MUTANT P53 SUPPRESSES THE GROWTH OF HUMAN LUNG-CANCER CELLS BEARING MULTIPLE GENETIC LESIONS
    TAKAHASHI, T
    CARBONE, D
    TAKAHASHI, T
    NAU, MM
    HIDA, T
    LINNOILA, I
    UEDA, R
    MINNA, JD
    CANCER RESEARCH, 1992, 52 (08) : 2340 - 2343
  • [26] p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
    Jean-Christophe Bourdon
    Marie P Khoury
    Alexandra Diot
    Lee Baker
    Kenneth Fernandes
    Mustapha Aoubala
    Philip Quinlan
    Colin A Purdie
    Lee B Jordan
    Anne-Catherine Prats
    David P Lane
    Alastair M Thompson
    Breast Cancer Research, 13
  • [27] p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
    Bourdon, Jean-Christophe
    Khoury, Marie P.
    Diot, Alexandra
    Baker, Lee
    Fernandes, Kenneth
    Aoubala, Mustapha
    Quinlan, Philip
    Purdie, Colin A.
    Jordan, Lee B.
    Prats, Anne-Catherine
    Lane, David P.
    Thompson, Alastair M.
    BREAST CANCER RESEARCH, 2011, 13 (01):
  • [28] RAS AND P53 EXPRESSION IN NON-SMALL-CELL LUNG-CANCER PATIENTS - P53 OVER-EXPRESSION CORRELATES WITH A POOR PROGNOSIS
    PAPADAKIS, E
    MALLIRI, A
    LINARDOPOULOS, S
    KARAIOSSIFIDI, H
    FIELD, JK
    SPANDIDOS, DA
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1992, 1 (04) : 403 - 413
  • [29] PCNA and p53
    Mighell, A
    ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B, 1995, 31B (06): : 403 - 404
  • [30] New therapeutic strategies to treat human cancers expressing mutant p53 proteins
    Giovanni Blandino
    Silvia Di Agostino
    Journal of Experimental & Clinical Cancer Research, 37
12345